Li J - Search Results

1

Cancer Cell enters reversible quiescence through Intracellular Acidification to resist Paclitaxel Cytotoxicity.

Jia M, Zheng D, Wang X, Zhang Y, Chen S, Cai X, Mo L, Hu Z, Li H, Zhou Z, Li J. Jia M, et al. Among authors: li j, li h. Int J Med Sci. 2020 Jun 29;17(11):1652-1664. doi: 10.7150/ijms.46034. eCollection 2020. Int J Med Sci. 2020. PMID: 32669967 Free PMC article.

2

A novel immunotherapy for superficial bladder cancer by the immobilization of streptavidin-tagged bioactive IL-2 on the biotinylated mucosal surface of the bladder wall.

Huang X, Yu HS, Chen Z, Li JL, Hu ZM, Gao JM. Huang X, et al. Chin J Cancer. 2010 Jun;29(6):611-6. doi: 10.5732/cjc.009.10640. Chin J Cancer. 2010. PMID: 20507734 Free article.

3

[Expression, purification and bioactivity evaluation of streptavidin-tagged human interleukin-21 fusion protein].

Fa PP, Zhang Z, Li JL, Hu ZM, Gao JM. Fa PP, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2010 Jun;30(6):1240-3, 1249. Nan Fang Yi Ke Da Xue Xue Bao. 2010. PMID: 20584646 Chinese.

4

A novel therapeutic vaccine of GM-CSF/TNFalpha surface-modified RM-1 cells against the orthotopic prostatic cancer.

Yin W, He Q, Hu Z, Chen Z, Qifeng M, Zhichun S, Zhihui Q, Xiaoxia N, Li J, Gao J. Yin W, et al. Among authors: li j. Vaccine. 2010 Jul 12;28(31):4937-44. doi: 10.1016/j.vaccine.2010.05.038. Vaccine. 2010. PMID: 20653081

5

[Norcantharidin inhibits DNA replication initiation protein Cdc6 in cancer cells].

Li JL, Cai YC, Hu ZM, Gao JM. Li JL, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2010 Aug;30(8):1851-3. Nan Fang Yi Ke Da Xue Xue Bao. 2010. PMID: 20813683 Chinese.

6

The therapeutic potential of SA-sCD40L in the orthotopic model of superficial bladder cancer.

Zhang Z, Xu X, Zhang X, Chen X, Chen Q, Dong L, Hu Z, Li J, Gao J. Zhang Z, et al. Among authors: li j. Acta Oncol. 2011 Oct;50(7):1111-8. doi: 10.3109/0284186X.2010.549838. Epub 2011 Jan 19. Acta Oncol. 2011. PMID: 21247263

7

[Preparation and characterization of reference samples of Mycobacterium tuberculosis culture filtrate protein-10 for time-resolved fluoroimmunoassay].

Guo FF, Zou LL, Wu YS, Hu ZM, Li JL, Lv JX, Gao JM. Guo FF, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2011 Jun;31(6):955-9. Nan Fang Yi Ke Da Xue Xue Bao. 2011. PMID: 21690044 Chinese.

8

Novel immunotherapy for metastatic bladder cancer using vaccine of human interleukin-2 surface-modified MB 49 cells.

Zhang X, Shi X, Li J, Hu Z, Guo F, Huang X, Zhang Z, Sun P, Jing Y, Gao J, Tan W. Zhang X, et al. Among authors: li j. Urology. 2011 Sep;78(3):722.e1-722.e6. doi: 10.1016/j.urology.2011.04.044. Epub 2011 Jul 13. Urology. 2011. PMID: 21741685

9

Sequential administration of GM-CSF and IL-2 surface-modified MB49 cells vaccines against the metastatic bladder cancer.

Shi X, Zhang X, Li J, Guo F, Hu Z, Jing Y, Bai L, Chen S, Wan P, Wang F, Gao J, Tan W. Shi X, et al. Among authors: li j. Urol Oncol. 2013 Aug;31(6):883-93. doi: 10.1016/j.urolonc.2011.08.001. Epub 2011 Sep 15. Urol Oncol. 2013. PMID: 21924648

10

A novel therapeutic vaccine of mouse GM-CSF surface modified MB49 cells against metastatic bladder cancer.

Zhang X, Shi X, Li J, Hu Z, Zhou D, Gao J, Tan W. Zhang X, et al. Among authors: li j. J Urol. 2012 Mar;187(3):1071-9. doi: 10.1016/j.juro.2011.10.126. Epub 2012 Jan 21. J Urol. 2012. PMID: 22266013

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194,981 results

Search Page

Filters